Dexmedetomidine
DrugDexmedetomidine+Lidocaine
NCT Number: NCT05439005
This study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.
Interested in participating?
Request Info18 year and older
Female
Interventional
Phase 3
Institut Curie Paris, Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dexmedetomidine+Lidocaine
Time frame: during the first 48 hours postoperatively
Time frame: end of surgery
Time frame: on arrival in the PACU
Time frame: in the PACU, at D0, D1 and D2
Time frame: in the PACU, at D0, D1 and D2
Time frame: in the PACU
Time frame: the first 48 hours postoperatively
Time frame: on D2, D4, M1, M3 and M6
Time frame: at discharge
Time frame: at discharge
Time frame: at discharge
Time frame: between D0 (date of surgery) and D30
Time frame: at discharge
Time frame: the first 48 hours postoperatively
Contact information is provided by the study sponsor or research team.
Anne-Claire COYNE, PhD
CONTACT
Mary SAAD, MD
CONTACT
Institut Curie
Other
Acronym: OFOBA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05461768
Breast Cancer, Breast Diseases
Fuzhou, Fujian, China
View Trial DetailsNCT07225309
Breast Cancer, Breast Cancer Stage III
New York, United States
View Trial DetailsNCT04360330
Breast Cancer, Breast Diseases
Miami, Florida, United States
View Trial DetailsNCT06922708
Breast Cancer, Breast Diseases
Roma, Italy
View Trial Details